Gastroenterology ASCs are seeing rising procedural demand, yet margins continue to erode—not because of volume, but because of missed strategic levers. Key opportunities lie in areas many practices underutilize: payer strategy, employer contracting, operational efficiency, and screening expansion.
In-network positioning is increasingly critical as independent dispute resolution (IDR) becomes a volume driver, while direct-to-employer contracting offers a largely untapped path to capture predictable, bundled revenue. At the same time, internal inefficiencies—device variation, poor scheduling, and underutilized block time—quietly inflate costs without improving throughput.
The biggest growth lever, however, sits outside the system: millions of unscreened patients following updated colorectal cancer guidelines. Closing even a fraction of that gap could translate into sustained, long-term volume growth.